Order Article Reprints

Bai Z, Xu M, Mei Y, Hu T, Zhang P, Chen M, Lv W, Lu C, Tan S. Generation of a Novel High-Affinity Antibody Binding to PCSK9 Catalytic Domain with Slow Dissociation Rate by CDR-Grafting, Alanine Scanning and Saturated Site-Directed Mutagenesis for Favorably Treating Hypercholesterolemia. Biomedicines. 2021; 9(12):1783. https://doi.org/10.3390/biomedicines9121783

Bai, Zhengli, Menglong Xu, Ying Mei, Tuo Hu, Panpan Zhang, Manman Chen, Wenxiu Lv, Chenchen Lu, and Shuhua Tan. 2021. "Generation of a Novel High-Affinity Antibody Binding to PCSK9 Catalytic Domain with Slow Dissociation Rate by CDR-Grafting, Alanine Scanning and Saturated Site-Directed Mutagenesis for Favorably Treating Hypercholesterolemia" Biomedicines 9, no. 12: 1783. https://doi.org/10.3390/biomedicines9121783

Bai, Z., Xu, M., Mei, Y., Hu, T., Zhang, P., Chen, M., Lv, W., Lu, C., & Tan, S. (2021). Generation of a Novel High-Affinity Antibody Binding to PCSK9 Catalytic Domain with Slow Dissociation Rate by CDR-Grafting, Alanine Scanning and Saturated Site-Directed Mutagenesis for Favorably Treating Hypercholesterolemia. Biomedicines, 9(12), 1783. https://doi.org/10.3390/biomedicines9121783